Oncotest GmbH and Debiopharm Announce a Successful Partnership in the Identification of Biomarker Candidates
4/24/2013 9:53:03 AM
More...
|
Ascepion Pharmaceuticals, Inc. and Debiopharm to Develop Cancer Drug for China
4/18/2013 11:29:37 AM
More...
|
Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm
1/9/2013 10:17:08 AM
More...
|
Chugai Pharmaceutical Co., Ltd. (Japan) and Debiopharm Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284
1/8/2013 10:48:22 AM
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Launches Debiopharm's Pamorelin® LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer
12/7/2012 11:33:55 AM
More...
|
Debiopharm Presents the "Debiopharm Group Life Sciences Award 2012" and Two "Junior Debiopharm Group Life Sciences Awards 2012" During the Annual EPFL SV- Life Science Symposium
8/31/2012 8:31:01 AM
More...
|
Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
8/27/2012 9:41:28 AM
More...
|
Curis, Inc. (CRIS) and Debiopharm Announce Initiation of Phase I-II Clinical Study of HSP90 Inhibitor Debio 0932
8/15/2012 9:24:14 AM
More...
|
Debiopharm - First Patient Treated in Phase III Study With Subcutaneous Administration of Debio 8206 for Treatment of Advanced Prostate Cancer
7/24/2012 9:52:45 AM
More...
|
Immunexpress , Debiopharm, and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis
6/19/2012 11:58:05 AM
More...
|
|